Targeting neoantigens to augment antitumour immunity

Area of Science:

• Oncology
• Immunology
• Cancer Genomics

Background:

• The past decade has seen a significant rise in understanding the interplay between the immune system and cancer.
• Tumorigenesis involves genomic mutations that can lead to the expression of tumor-specific proteins, known as neoantigens.
• Neoantigens present a promising target for immunotherapy due to their selective expression on cancer cells, potentially reducing immune tolerance and autoimmunity.

Purpose of the Study:

• To review the evidence supporting neoantigen recognition by the immune system.
• To discuss the potential of targeting neoantigens for enhanced anti-tumor immunity.
• To present a framework for personalized cancer immunotherapy based on neoantigen targeting.

Main Methods:

• Review of emerging scientific literature on neoantigens and cancer immunity.
• Analysis of the mechanisms by which neoantigens are recognized by the immune system.
• Discussion of a framework for personalized immunotherapy strategies.

Main Results:

• Growing evidence indicates that the immune system recognizes neoantigens.
• Targeting neoantigens shows potential for increasing anti-tumor immune responses.
• A framework for personalized cancer immunotherapy through neoantigen identification and targeting is proposed.

Conclusions:

• Neoantigens are key targets for enhancing anti-tumor immunity.
• Personalized immunotherapy leveraging neoantigens offers a promising approach to cancer treatment.
• Further research is needed to overcome obstacles and fully realize the benefits of neoantigen-targeted immunotherapy.